by Meriem Bouslouk-Marx | Mar 15, 2021 | News
With Advanced Therapy Medicinal Products (ATMPs), especially those for the treatment of rare diseases – innovative but also very expensive therapies – entering the market, a new challenge for payers has arisen. How can innovative medicinal products be financed in the... 
by Meriem Bouslouk-Marx | Jul 15, 2020 | News
The International Federation of Pharmaceutical Manufacturers & Associations IFPMA, the European Federation of Pharmaceutical Industries and Associations EFPIA and the German Association of Research-Based Pharmaceutical Companies vfa organised an online event to... 
by Meriem Bouslouk-Marx | Dec 1, 2019 | News
Following the invitation of Sindusfarma (Syndicate of the Pharmaceutical Products Industry in the State of São Paulo) and Anvisa (Brazilian Health Regulatory Agency), stakeholders met to discuss Brazil’s challenges with advanced therapies. The two days with... 
by Meriem Bouslouk-Marx | Jul 5, 2019 | News
Professor Sami Haddadin, Director of the Munich School of Robotics and Machine Intelligence at the Technical University of Munich, started with a historical introduction to the subject. The Dartmouth summer research project on artificial intelligence (AI) in 1956 was... 
by Meriem Bouslouk-Marx | May 28, 2019 | News
Under the patronage of René Röspel, Social Democratic Party of Germany (SPD) parliamentary group, a multi-stakeholder session on rare diseases took place at the Bundestag. This platform offered the audience a discourse with representatives from policy, patients,...